Publication: Pneumococcal serotypes in children in 4 European countries
Loading...
Identifiers
Publication date
2010-09
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Centers for Disease Control and Prevention (CDC)
Metrics
Export
Abstract
After heptavalent pneumococcal conjugate vaccine (PCV7) was marketed in France, Spain, Belgium, and England and Wales (United Kingdom), invasive disease from non-PCV7 serotypes (NVT) increased. Adjusted serotype-specific incidences among children <15 years of age were compared between 1999-2002 (prevaccine) and 2005-2006 (postmarketing). Vaccine coverage increased to approximately 32%-48% in France, Spain, and Belgium but remained <1% in England and Wales. Serotype 1 incidence rose in all age groups and countries (incidence rate ratio [IRR] 1.3-4.2; p<0.004), independently of PCV7 use, but incidence of serotypes 7F and 19A increased most in France, Spain, and Belgium (IRR 1.9-16.9 in children <5 years; p<0.001), where PCV7 coverage was greater. Vaccine-induced replacement of PCV7 serotypes possibly contributed to NVT increases, as did secular trends. New vaccines targeting these serotypes are available, but serotype dynamics needs further exploration that accounts for underreporting and prevaccine trends.
Description
Keywords
MeSH Terms
Adolescent Belgium Child Child, Preschool Female France Heptavalent Pneumococcal Conjugate Vaccine Humans Incidence Infant Infant, Newborn Male Meningitis, Pneumococcal Pneumococcal Infections Pneumococcal Vaccines Prospective Studies Serotyping Spain Streptococcus pneumoniae Time Factors United Kingdom
DeCS Terms
Bibliographic citation
Emerg Infect Dis. 2010 Sep;16(9):1428-39.